C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
AUTOR(ES)
Schlotter, Claus M
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=154146Documentos Relacionados
- c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?
- Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer.
- Node-negative breast cancer patients exposed to unnecessary perioperative risk and increased long-term morbidity.
- Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer
- Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection.